Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis in pregnancy.
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
Glatiramer Acetate Guards Against Rapid Memory Decline During Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Combined structural and functional patterns discriminating upper limb motor disability in multiple sclerosis using multivariate approaches.
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
Subclinical myocardial dysfunction in multiple sclerosis patients remotely treated with mitoxantrone: evidence of persistent diastolic dysfunction.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.
Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells.
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience.
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.

Pages